Stock Events

Biotoxtech 

₩5,000
2
+₩0+0% Today

Statistics

Day High
5,040
Day Low
4,935
52W High
8,200
52W Low
4,805
Volume
28,215
Avg. Volume
203,783
Mkt Cap
80.91B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

31DecConfirmed
Q1 2017
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
-126.51
3.66
133.83
264
Expected EPS
N/A
Actual EPS
-126.5104

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 086040.KQ. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
STPharmLtd
237690.KQ
Mkt Cap1.83T
Korea Drug Development Fund invests in biotech and pharmaceutical companies, directly competing with Biotoxtech in the drug development sector.
Access Bio
950130.KQ
Mkt Cap223.5B
Osstem Implant is involved in medical research and development, competing in the biotech space similar to Biotoxtech.
e-Credible
092130.KQ
Mkt Cap152.35B
Seegene Inc specializes in molecular diagnostics, a field closely related to Biotoxtech's biotechnological testing and analysis.
Seegene
096530.KQ
Mkt Cap957.5B
Sillajen Biotherapeutics focuses on biopharmaceuticals, directly competing with Biotoxtech in the biotech industry.
Komipharm International.
041960.KQ
Mkt Cap298.87B
Curevac is engaged in the development of vaccines and therapeutic proteins, competing in the biopharmaceutical sector like Biotoxtech.
Humasis.
205470.KQ
Mkt Cap171.88B
Pharmicell works on cell therapy products, which is a direct competition to Biotoxtech's offerings in biotechnological therapies.
Telcon RF Pharmaceutical
200230.KQ
Mkt Cap84.68B
CJ HealthCare is a major player in healthcare and biopharmaceuticals, competing across several of Biotoxtech's key areas.
CaregenLtd
214370.KQ
Mkt Cap1.13T
Genexine is involved in the clinical stage biotechnology, similar to Biotoxtech's focus on biotechnological research and development.
Enzychem Lifesciences
183490.KQ
Mkt Cap0
GenNBio focuses on immunotherapy products, competing in the biotech sector where Biotoxtech is also a key player.
Kolon TissueGene
950160.KQ
Mkt Cap0
JYP Entertainment, while primarily an entertainment company, has ventured into biotech, indirectly competing with Biotoxtech.

About

Biotoxtech Co., Ltd. engages in the safety evaluation of pharmaceuticals, foods, cosmetics, cell therapeutics, chemicals, agrochemicals, and medical equipment in South Korea. It is involved in the PK/TK, ADME, and RI analysis, as well as validation and bio analysis; efficacy evaluation and screening materials; clinical pathology and business contract of histopathology; new drug development; and business consulting and vicegerent of nonclinical trial activities. The company's safety evaluation research field includes general toxicity studies, carcinogenicity studies, local toxicity studies, reproductive and developmental studies, genotoxicity studies, immunotoxicity studies, safety pharmacology, ecotoxicology studies, histopathology/clinical pathology, and juvenile animal toxicity studies. Biotoxtech Co., Ltd. was founded in 2000 and is headquartered in Cheongwon, South Korea.
Show more...
CEO
Mr. Jong-Koo Kang Ph.D.
Employees
208
Country
KR
ISIN
KR7086040003

Listings